# Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia

> **NCT03971565** · — · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 47 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** Blood sample 5 milliliter

## Key facts

- **NCT ID:** NCT03971565
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-19
- **Primary completion:** 2021-03-18
- **Final completion:** 2021-03-18
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2019-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03971565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03971565, "Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03971565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*